Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Corticotrophin-releasing factor receptor 1 (CRHR1) is a G-protein coupled receptor that binds neuropeptides from the corticotropin-releasing hormone family, primarily corticotropin-releasing hormone (CRH) and urocortin (UCN). It plays a central role in coordinating endocrine, autonomic, and behavioral responses to stress via the hypothalamic-pituitary-adrenal axis (HPA axis). Dysregulation has been implicated as a potential target for treatment of depression and anxiety disorders due to its central role in stress response modulation.
Agonist; Antagonist; Modulation of adenylyl cyclase signaling pathway
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Corticotrophin-releasing factor receptor 1 (CRHR1).